Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Esther Rajavelu > Profile

Esther Rajavelu

Affiliations

  • See Remarks at Spero Therapeutics Inc. (SPRO), 2025-05-07
  • Chief Financial Officer at Fulcrum Therapeutics Inc. (FULC), 2023-02-13
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SPRO $0.78 20,689 $16,137.42 724,720 2025-02-05 Filing
SPRO $1.30 17,245 $22,418.50 379,270 2024-11-08 Filing
SPRO $1.31 23,351 $30,589.81 396,515 2024-11-07 Filing